NEXENTIS TECHNOLOGIES INC. Increase (Decrease) in Long-term Receivables, Current
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Increase (Decrease) in Long-term Receivables, Current of $47.00 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInLongTermReceivablesCurrent · last filed 2025-11-13
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in long-term receivables, current for the quarter ending 2025-09-30 was -$54.00K.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in long-term receivables, current for the quarter ending 2025-06-30 was $105.00K.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in long-term receivables, current for the quarter ending 2025-03-31 was -$4.00K.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in long-term receivables, current for the quarter ending 2024-12-31 was -$88.00K.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in long-term receivables, current for fiscal 2024 was -$56.00K.
| Period end | Increase (Decrease) in Long-term Receivables, Current 3 month | Increase (Decrease) in Long-term Receivables, Current 6 month | Increase (Decrease) in Long-term Receivables, Current 9 month | Increase (Decrease) in Long-term Receivables, Current 9 month as first filed | Increase (Decrease) in Long-term Receivables, Current 12 month |
|---|---|---|---|---|---|
| 2025-09-30 | -$54.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $51.00K derived: sum of 2 quarters · filed 2025-11-13 | $47.00K 10-Q · filed 2025-11-13 | -$41.00K derived: sum of 4 quarters · filed 2025-11-13 | |
| 2025-06-30 | $105.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $101.00K 10-Q · filed 2025-08-14 | $13.00K derived: sum of 3 quarters · filed 2025-08-14 | ||
| 2025-03-31 | -$4.00K 10-Q · filed 2025-05-15 | -$92.00K derived: sum of 2 quarters · filed 2025-05-15 | |||
| 2024-12-31 | -$88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$56.00K 10-K · filed 2025-03-31 | |||
| 2024-09-30 | $32.00K 10-Q · filed 2025-11-13 | $32.38K 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |